GENE202 is a single dose gene therapy for patients with rare metabolic disease, methylmalonic acidaemia.

Gold drill hits, new discoveries and standout assays drove sharp moves across small-cap resources, with OLY, LAT and MHM ...

By Ojo Emmanuel AdemolaThe year 2026 stands as a watershed moment for global cybersecurity leadership. Threat actors have ...

Unity Software rebounds after scrapping its pricing plan and revamping products, but profits lag. Read the full analysis here ...

Spectacular Results Up To 34.3% Antimony At Oaky Creek NSW. Red Mountain Mining Limited (ASX:RMX) (OTCMKTS:RMXFF), a Critical Minerals exploration and development company with an established and growi ...

Bill Rosborough and his son Jon stopped their pickup truck near a 40-acre cornfield and pointed to a white PVC pipe that rose ...

In late 2025, Israel officially announced its recognition of Somaliland, a self-declared independent region in northern Somalia that has asserted its sovereignty since 1991 but remains largely ...

Ocugen, Inc. gene therapy outlook: key 2026 catalysts, Phase 2/3 eye-disease data, BLA plans to 2028, and risks. Click for ...

BAE Systems, Maritime Solutions Norfolk, Norfolk, Virginia, was awarded a $204,160,189 firm-fixed-price (FFP) contract action ...

Explores turning the browser into a policy enforcement point within a Zero Trust framework, covering governance, MFA, device ...

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable ...